Fostair NEXhaler indicated for COPD
Fostair NEXhaler (beclometasone diproprionate, formoterol fumarate dihydrate; Chiesi) is now indicated for patients with chronic obstructive pulmonary disease. Further changes to the summary of product characteristics reflect this addition.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20200187
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com